Hearth Failure With Reduced Ejection Fraction (HFrEF)

DBCOND0080197Cardiovascular Diseases

Hearth Failure With Reduced Ejection Fraction (HFrEF) is the indication for 1 drug in DrugBank. It is covered by 1 curated, structured indication.

Also known as: Heart Failure, Systolic · Reduced Ejection Fraction Heart Failure · Systolic Heart Failure · Heart Failure With Reduced Ejection Fraction · Heart Failure With Reduced Ejection Fraction (HF-rEF)
Classified under: Cardiovascular Diseases
Indicated drugs: Ramipril

Resolves to

Vocabularies

MeSHM0502059ICD-10I50.1SNOMED CT155376009MedDRA10024120UMLSC0023212

What you can answer from here — as of November 01, 2026

1Indicated drugWith each drug's targets and mechanism

Listed above

1Structured indicationPopulation, line of therapy, route and combination as fields, not prose

210Clinical trialsPhase, status and sponsor resolved per trial

Which approved drugs for Hearth Failure With Reduced Ejection Fraction (HFrEF) share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account